Literature DB >> 3926114

Prognosis of colonic Crohn's disease.

P R Elliott, J K Ritchie, J E Lennard-Jones.   

Abstract

Entities:  

Mesh:

Year:  1985        PMID: 3926114      PMCID: PMC1416372          DOI: 10.1136/bmj.291.6489.178

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  4 in total

1.  Crohn's disease involving the colon: an audit of clinical management.

Authors:  R Allan; D M Steinberg; J A Williams; W T Cooke
Journal:  Gastroenterology       Date:  1977-10       Impact factor: 22.682

2.  Clinical outcome of the first ten years of ulcerative colitis and proctitis.

Authors:  J K Ritchie; J Powell-Tuck; J E Lennard-Jones
Journal:  Lancet       Date:  1978-05-27       Impact factor: 79.321

3.  Proctocolitis and Crohn's disease of the colon: a comparison of the clinical course.

Authors:  J E Lennard-Jones; J K Ritchie; W J Zohrab
Journal:  Gut       Date:  1976-06       Impact factor: 23.059

4.  Prognosis in Crohn's disease--based on results from a regional patient group from the county of Copenhagen.

Authors:  V Binder; C Hendriksen; S Kreiner
Journal:  Gut       Date:  1985-02       Impact factor: 23.059

  4 in total
  5 in total

1.  The results of surgery for large bowel Crohn's disease.

Authors:  J K Ritchie
Journal:  Ann R Coll Surg Engl       Date:  1990-05       Impact factor: 1.891

Review 2.  Medical or surgical treatment for Crohn's disease?

Authors:  R N Allan
Journal:  Postgrad Med J       Date:  1988-10       Impact factor: 2.401

3.  Crohn's disease in the elderly.

Authors:  J Rhodes; J Rose
Journal:  Br Med J (Clin Res Ed)       Date:  1985-10-26

4.  Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn's disease.

Authors:  D G Forcione; M J Rosen; J B Kisiel; B E Sands
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

5.  Two types of colorectal carcinoma in Crohn's disease.

Authors:  J Kyle; S W Ewen
Journal:  Ann R Coll Surg Engl       Date:  1992-11       Impact factor: 1.891

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.